ANRO
NYSE · Pharmaceuticals
Alto Neuroscience Inc
$30.76
+0.13 (+0.42%)
Open$30.71
Previous Close$30.63
Day High$31.46
Day Low$30.36
52W High$37.48
52W Low$3.59
Volume—
Avg Volume477.1K
Market Cap1.21B
P/E Ratio—
EPS$-2.44
SectorPharmaceuticals
Analyst Ratings
Strong Buy
17 analysts
Price Target
-27.9% upside
Current
$30.76
$30.76
Target
$22.17
$22.17
$14.63
$22.17 avg
$27.87
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 112.34M | 107.15M | 117.41M |
| Net Income | 25.21M | 21.35M | 24.46M |
| Profit Margin | 22.4% | 19.9% | 20.8% |
| EBITDA | 29.11M | 29.85M | 33.13M |
| Free Cash Flow | 25.43M | 19.85M | 18.41M |
| Rev Growth | +16.8% | +14.3% | +23.4% |
| Debt/Equity | 0.26 | 0.26 | 0.26 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |